People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Pharmaceuticals, Other Technology, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Slayback Pharma Ltd Liability Co | — | Pharmaceuticals | Series B | $35.0M | $1.2B | 2016 |
| We Comes Before Me Corp. | — | Other Technology | Series A | $14.6M | $64.8M | 2023 |
| Zebrium, Inc. | — | Other Technology | Seed | $7.3M | $136.3M | 2018 |
| Flebo Inc. | — | Other Health Care | Series A | $5.0M | $42.4M | 2022 |
| Pro Football Network Inc. | — | Other | Seed | $1.3M | $8.5M | 2023 |
Ajay Singh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ajay Singh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ali J. Satvat | 1 | 4 |
| Eduard Khachian | 1 | 1 |
| Matthew Cannata | 1 | 1 |
| Aaron Sutton | 1 | 1 |
| Matthew Infante | 1 | 1 |
| Anirudh Kumar | 1 | 1 |
| Roderick Ernest Bagg | 1 | 1 |
| Larry Robert Lancaster, Jr. | 1 | 1 |
| Neel J. Varshney | 1 | 1 |
| Gyan J. Singh | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.